AMRI’s Holywell, UK, manufacturing facility has received a GMP certificate following an inspection in October 2011. The site also passes a US FDA audit in June 2011. AMRI said the former Excelsyn facility can now produce registered intermediates and active ingredients for use in humans and expands the range of projects that it can now conduct at this facility.
AMRI
Thursday 19 January 2012
AMRI UK site receives GMP certificate
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment